???pagination.result.count???
???pagination.result.page???
1
Kir6.2 activation by sulfonylurea receptors: a different mechanism of action for SUR1 and SUR2A subunits via the same residues. , Principalli MA., Physiol Rep. September 1, 2015; 3 (9):
Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. , Jin JY., Pharmacol Res. September 1, 2007; 56 (3): 237-47.
Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. , Gribble FM., J Diabetes Complications. January 1, 2003; 17 (2 Suppl): 11-5.
Amiloride derivatives are potent blockers of KATP channels. , Bollensdorff C., Naunyn Schmiedebergs Arch Pharmacol. October 1, 2001; 364 (4): 351-8.
Structural basis for the interference between nicorandil and sulfonylurea action. , Reimann F., Diabetes. October 1, 2001; 50 (10): 2253-9.
Chromanol 293B, a blocker of the slow delayed rectifier K+ current (IKs), inhibits the CFTR Cl- current. , Bachmann A., Naunyn Schmiedebergs Arch Pharmacol. June 1, 2001; 363 (6): 590-6.
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. , D'hahan N., Proc Natl Acad Sci U S A. October 12, 1999; 96 (21): 12162-7.
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers. , D'hahan N., Mol Pharmacol. August 1, 1999; 56 (2): 308-15.
Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. , Gribble FM., Diabetes. September 1, 1998; 47 (9): 1412-8.